Respiratory distress syndrome. Respiratory distress syndrome of newborn
Conditions
Interventions
Intervention 1: Intervention group (Humidified High Flow Nasal Cannula group) who dissent from NCPAP at Fio2=30% and receive 2 Lit/min O2 via cannula nasal. Intervention 2: Control group: who are conn
Treatment - Other
Intervention group (Humidified High Flow Nasal Cannula group) who dissent from NCPAP at Fio2=30% and receive 2 Lit/min O2 via cannula nasal
Control group: who are connected to the NCPAP at Fio2=21% to achieve a stable condition for 24 hours.
Sponsors
Vice chancellor for research, Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
28 Years to 37 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: preterm infants with respiratory distress syndrome (RDS) and gestational age (28-37 weeks) who require NCPAP; being stable on NCPAP at Fio2=30% for 6 hours; no clinical sign of RDS such as tachypnea, sever apnea, intercostals retraction and nasal flaring. Exclusion criteria: infants with genetic anomalies; congenital cyanotic heart disease; genetic anomalies in airways or chest; pulmonary hypoplasy; genetic neurologic disease; neuro-mascular disease; inter ventricular hemorrhages (grade 3-4) and hydrocephaly.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Apnea. Timepoint: From the time on the Nasal Continuous Positive Airway Pressure (NCPAP) till disparting from O2. Method of measurement: Observation.;Duration of need for respiratory support. Timepoint: From the time on the Nasal Continuous Positive Airway Pressure (NCPAP) till disparting from O2. Method of measurement: Observation.;Duration of O2 treatment. Timepoint: From the time on the Nasal Continuous Positive Airway Pressure (NCPAP) till disparting from O2. Method of measurement: Observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Alireza Eshghi
Isfahan University of Medical Sciences
Outcome results
None listed